Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Heart (British Cardiac Society)|June 25, 2020
Community pharmacy-based study of adherence to non-vitamin K antagonist oral anticoagulantsAndreas Capiau, Els Mehuys, Inge Van Tongelen, et al.Sleep|November 22, 2022
Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary careKristien Coteur, Gilles Henrard, Birgitte Schoenmakers, et al.International Journal of Environmental Research and Public Health|July 2, 2021
Family Physician Perceptions of Climate Change, Migration, Health, and Healthcare in Sub-Saharan Africa: An Exploratory StudyCharlotte Scheerens, Els Bekaert, Sunanda Ray, et al.BMJ Open|February 2, 2022
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocolNiels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, et al.Family Practice|August 27, 2021
Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, BelgiumJoachim Mariën, Ann Ceulemans, Diana Bakokimi, et al.BMJ Open|February 21, 2020
Effectiveness of a blended care programme for the discontinuation of benzodiazepine use for sleeping problems in primary care: study protocol of a cluster randomised trial, the Big Bird trialKristien Coteur, Marc Van Nuland, Marc Vanmeerbeek, et al.Lancet (London, England)|September 28, 2025
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trialJan Yvan Verbakel, Ruben Burvenich, Erinn D'hulster, et al.BMJ Open|September 19, 2022
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upNiels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, et al.BMJ Open|May 2, 2023
Validation of a rapid SARS-CoV-2 antibody test in general practiceJulie Domen, Jan Yvan Jos Verbakel, Niels Adriaenssens, et al.BMC Medical Education|November 7, 2022
Challenges and opportunities for general practice specific CME in Europe - a narrative review of seven countriesChristin Löffler, Attila Altiner, Sandra Blumenthal, et al.Pageof 10